Cargando…
Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications
Proteins derived from the natural extracellular matrix like collagen or gelatin are common in clinical research, where they are prized for their biocompatibility and bioactivity. Cells are able to adhere, grow and remodel scaffolds based on these materials. Usually, collagen and gelatin are sourced...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787575/ https://www.ncbi.nlm.nih.gov/pubmed/31480684 http://dx.doi.org/10.3390/jfb10030039 |
_version_ | 1783458295151853568 |
---|---|
author | Gellermann, Pia Schneider-Barthold, Caroline Bolten, Svenja Nicolin Overfelt, Ethan Scheper, Thomas Pepelanova, Iliyana |
author_facet | Gellermann, Pia Schneider-Barthold, Caroline Bolten, Svenja Nicolin Overfelt, Ethan Scheper, Thomas Pepelanova, Iliyana |
author_sort | Gellermann, Pia |
collection | PubMed |
description | Proteins derived from the natural extracellular matrix like collagen or gelatin are common in clinical research, where they are prized for their biocompatibility and bioactivity. Cells are able to adhere, grow and remodel scaffolds based on these materials. Usually, collagen and gelatin are sourced from animal material, risking pathogenic transmission and inconsistent batch-to-batch product quality. A recombinant production in yeast circumvents these disadvantages by ensuring production with a reproducible quality in animal-component-free media. A gelatin mimetic protein, based on the alpha chain of human collagen I, was cloned in Pichia pastoris under the control of the methanol-inducible alcohol oxidase (AOX1) promoter. A producing clone was selected and cultivated at the 30 L scale. The protein was secreted into the cultivation medium and the final yield was 3.4 g·L(−1). Purification of the target was performed directly from the cell-free medium by size exclusion chromatography. The gelatin mimetic protein was tested in cell culture for biocompatibility and for promoting cell adhesion. It supported cell growth and its performance was indistinguishable from animal-derived gelatin. The gelatin-mimetic protein represents a swift strategy to produce recombinant and human-based extracellular matrix proteins for various biomedical applications. |
format | Online Article Text |
id | pubmed-6787575 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67875752019-10-16 Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications Gellermann, Pia Schneider-Barthold, Caroline Bolten, Svenja Nicolin Overfelt, Ethan Scheper, Thomas Pepelanova, Iliyana J Funct Biomater Article Proteins derived from the natural extracellular matrix like collagen or gelatin are common in clinical research, where they are prized for their biocompatibility and bioactivity. Cells are able to adhere, grow and remodel scaffolds based on these materials. Usually, collagen and gelatin are sourced from animal material, risking pathogenic transmission and inconsistent batch-to-batch product quality. A recombinant production in yeast circumvents these disadvantages by ensuring production with a reproducible quality in animal-component-free media. A gelatin mimetic protein, based on the alpha chain of human collagen I, was cloned in Pichia pastoris under the control of the methanol-inducible alcohol oxidase (AOX1) promoter. A producing clone was selected and cultivated at the 30 L scale. The protein was secreted into the cultivation medium and the final yield was 3.4 g·L(−1). Purification of the target was performed directly from the cell-free medium by size exclusion chromatography. The gelatin mimetic protein was tested in cell culture for biocompatibility and for promoting cell adhesion. It supported cell growth and its performance was indistinguishable from animal-derived gelatin. The gelatin-mimetic protein represents a swift strategy to produce recombinant and human-based extracellular matrix proteins for various biomedical applications. MDPI 2019-09-02 /pmc/articles/PMC6787575/ /pubmed/31480684 http://dx.doi.org/10.3390/jfb10030039 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gellermann, Pia Schneider-Barthold, Caroline Bolten, Svenja Nicolin Overfelt, Ethan Scheper, Thomas Pepelanova, Iliyana Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications |
title | Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications |
title_full | Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications |
title_fullStr | Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications |
title_full_unstemmed | Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications |
title_short | Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications |
title_sort | production of a recombinant non-hydroxylated gelatin mimetic in pichia pastoris for biomedical applications |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787575/ https://www.ncbi.nlm.nih.gov/pubmed/31480684 http://dx.doi.org/10.3390/jfb10030039 |
work_keys_str_mv | AT gellermannpia productionofarecombinantnonhydroxylatedgelatinmimeticinpichiapastorisforbiomedicalapplications AT schneiderbartholdcaroline productionofarecombinantnonhydroxylatedgelatinmimeticinpichiapastorisforbiomedicalapplications AT boltensvenjanicolin productionofarecombinantnonhydroxylatedgelatinmimeticinpichiapastorisforbiomedicalapplications AT overfeltethan productionofarecombinantnonhydroxylatedgelatinmimeticinpichiapastorisforbiomedicalapplications AT scheperthomas productionofarecombinantnonhydroxylatedgelatinmimeticinpichiapastorisforbiomedicalapplications AT pepelanovailiyana productionofarecombinantnonhydroxylatedgelatinmimeticinpichiapastorisforbiomedicalapplications |